Chris Chorley

Associate Director, Regulatory Affairs CMC at Biogen

Speaker

Chris has worked in the pharmaceutical industry for approximately 18 years. He began his career at AstraZeneca, working initially as a synthetic organic chemist within oncology research, before joining the CMC regulatory compliance group in 2011. Chris held positions of increasing responsibility with Genpact and Ipsen, before joining Biogen in 2020. He currently leads regulatory CMC activities for small molecule and oligonucleotide programs at various stages of development and commercialisation. Chris holds a master’s degree in chemistry from the University of York, UK.